STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Regeneron Pharmaceuticals Inc. (REGN)

NASDAQ: Health Care

Get a 5-page Ratings Report on (REGN) now
$242.76 10.05 | 4.32%
Today's Range: 230.51 - 244.26
REGN Avg. Daily Volume: 1,123,900
06/18/13 - 4:00 PM ET
 
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 1.38B 445.82M 459.07M 379.27M
Cost of Sales 47.52M 4.22M 2.09M -12.56M
Gross Operating Profit 1.33B 441.61M 456.98M 391.83M
Selling, General, and Administrative Expenses 210.76M 117.26M 65.20M 52.92M
Research & Development 625.55M 529.51M 489.25M 398.76M
Operating Income before D & A (EBITDA) 494.65M -205.16M -97.47M -59.86M
Depreciation & Amortization 36.94M 31.08M 19.69M 14.25M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 2.01M 3.55M 2.12M 4.49M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 459.72M -232.69M -115.04M -69.62M
Interest Expense 45.30M 21.28M 9.12M 2.34M
Pre-Tax Income 414.42M -253.97M -124.16M -71.95M
Income Taxes -335.85M -1.13M 0.00 -4.12M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 750.27M -221.76M -104.47M -67.83M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 750.27M -221.76M -104.47M -67.83M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 750.27M -221.76M -104.47M -67.83M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
750.27M -221.76M -104.47M -67.83M
Preferred Dividends
Net Income Available To Common 750.27M -221.76M -104.47M -67.83M
Basic EPS from Continuing Ops. 7.92 -2.45 -1.26 -0.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 7.92 -2.45 -1.26 -0.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.92 -2.45 -1.26 -0.85
Basic Normalized Net Income/Share 7.92 -2.45 -1.26 -0.85
EPS fr Continuing Ops. 6.75 -2.45 -1.26 -0.85
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 6.75 -2.45 -1.26 -0.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 6.75 -2.45 -1.26 -0.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.75 -2.45 -1.26 -0.85
Dividends Paid per Share 0.00 0.00 0.00 0.00
(REGN) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
US 10 Yr 2.182% +0.011

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs